ANIDULAFUNGIN Pfizer subst sèche 100 mg flac

7680675730018 CH-67573 J02AX06 08.06.0.

Reimbursement limitations:

ECALTA3

Traitement des candidémies et des formes invasives de la candidose chez les patients âgés d'1 …

ANIDULAFUNGIN Pfizer subst sèche 100 mg flac
ANIDULAFUNGIN Pfizer subst sèche 100 mg flac
ANIDULAFUNGIN Pfizer subst sèche 100 mg flac
1 / 3
google

Details

Product number
6757301
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
Praeparatio cryodesiccata: anidulafunginum 100 mg, fructosum, mannitolum, polysorbatum 80, acidum tartaricum, pro vitro.

Articles (1)

Anidulafungin Pfizer 100 mg, Pulver zur Herstellung einer Infusionslösung
Pulver
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
04/03/2022
Professional SmPC
Français
04/03/2022
Professional SmPC
Italien
04/03/2022

Detailed composition

Substance Quantity Type Category
PRC
100.0 MG Substance Wirkstoff (Principe actif)
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK

Reimbursement information

Public price
CHF 381.95
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/08/2020

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
67573
Drug name
Anidulafungin Pfizer 100 mg, Pulver zur Herstellung einer Infusionslösung
Galenic form
PULP
ATC Code
J02AX06
Authorization status
Z
Authorization category
Category C
Dispensation category
A
First authorization
03/09/2019
Authorization expiration date
31/12/9999
IT number
08.06.0.
Domain
Human medicine
Field of application
Antimykotikum

Packaging details

Description (FR)
ANIDULAFUNGIN Pfizer subst sèche 100 mg flac
Description (DE)
ANIDULAFUNGIN Pfizer Trockensub 100 mg Durchstf
Market launch
03/09/2019
Narcotic (BTM)
No

Original drug

Ecalta, Pulver zur Herstellung einer Infusionslösung
CHF 442.80
View original